1. In patients with untreated paroxysmal atrial fibrillation, catheter ablation was associated with reduced rates of persistent atrial fibrillation and tachyarrhythmias compared to pharmacotherapies.
2. Catheter ablation was besides associated with a little complaint of superior adverse events erstwhile compared to antiarrhythmic pharmacotherapy.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Atrial fibrillation is an irregular and accelerated bosom bushed that tin beryllium progressive and chronic. It is associated with a scope of complications, specified arsenic humor clots and bosom failure. Currently, the optimum strategy for treating atrial fibrillation with respect to establishing power of ventricular bushed is unclear. The main techniques are catheter ablation and pharmacologic power done antiarrhythmic medications. This survey was a multi-center randomized proceedings conducted successful Canada investigating the effectiveness and information illustration of azygous ablation exertion against antiarrhythmic pharmacotherapy. Patients with aboriginal paroxysmal atrial fibrillation who are symptomatic and person ne'er antecedently been treated were included. This survey recovered that catheter ablation was much effectual than pharmacotherapy astatine reducing rates of astatine slightest 1 occurrence of persistent atrial fibrillation and rates of recurrent tachyarrhythmias aft the commencement of the trial. It was besides associated with an improved information illustration successful presumption of a little proportionality of patients experiencing a superior adverse event. Although, this survey is constricted by important crossing implicit of attraction arms (unidirectionally from pharmacotherapy to catheter ablation). Further, results are not generalizable beyond the circumstantial anti-arrhythmic medications and ablation techniques which were utilized.
Click to work the survey successful NEJM
In-Depth [randomized controlled trial]: This survey was a multicenter, randomized controlled proceedings involving 18 survey sites successful Canada which investigated the efficacy and information outcomes of cryoballoon ablation compared to anti-arrhythmic pharmacotherapy successful patients with paroxysmal atrial fibrillation. Persons older than 18 years aged who were symptomatic and not antecedently treated were included if they had electrocardiogram-confirmed documentation of atrial fibrillation wrong the erstwhile 24 months. All patients included were implanted with a cardiac show to observe cardiac rhythm activity. After the exertion of enactment criteria, 303 patients were randomly assigned to person ablation (n=154) oregon pharmacotherapy (n=149). The superior result of involvement was the occurrence of astatine slightest 1 occurrence of persistent atrial fibrillation wrong 36 months. Additional outcomes of involvement included recurrence of atrial tachyarrhythmia, Atrial Fibrillation Effect connected Quality-of-Life survey (AFEQT) score, and adverse events. Results of the superior investigation recovered that patients receiving pharmacotherapy were much apt to person astatine slightest 1 occurrence of persistent atrial fibrillation than patients receiving ablation (Hazard Ratio [HR], 0.25; 95% Confidence Interval [CI], 0.09 to 0.70), and much apt to person recurrent atrial tachyarrhythmia (HR, 0.51; 95% CI 0.38 to 0.67). At the last follow-up, 23.5% of patients successful the pharmacotherapy radical (n=35) and 11.0% of patients successful the ablation radical (n=17) had experienced a superior adverse effect. This survey supports catheter ablation arsenic an archetypal mechanics of bushed power for paroxysmal symptomatic atrial fibrillation not antecedently treated.
Image: PD
©2023 2 Minute Medicine, Inc. All rights reserved. No works whitethorn beryllium reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire astir licensing here. No nonfiction should beryllium construed arsenic aesculapian proposal and is not intended arsenic specified by the authors oregon by 2 Minute Medicine, Inc.
English (US)